Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascual Sanz

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Molecular Cell|November 14, 2017
An Attachment-Independent Biochemical Timer of the Spindle Assembly CheckpointJunbin Qian, Maria Adelaida García-Gimeno, Monique Beullens, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 21, 2011
Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolismPhilippe Couarch, Santiago Vernia, Isabelle Gourfinkel-An, et al.
Protein Science : a Publication of the Protein Society|July 1, 2005
Structure-function analysis of the alpha5 and the alpha13 helices of human glucokinase: description of two novel activating mutationsLeda Pedelini, Maria Adelaida Garcia-Gimeno, Alberto Marina, et al.
Human Molecular Genetics|October 9, 2003
Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulationMaria Elena Fernández-Sánchez, Olga Criado-García, Karen E Heath, et al.
International Journal of Molecular Sciences|January 21, 2023
Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative StressCarlos Romá-Mateo, Sheila Lorente-Pozo, Lucía Márquez-Thibaut, et al.
ACS Chemical Neuroscience|December 28, 2021
Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington DiseaseMarta Vela, María Adelaida García-Gimeno, Ana Sanchis, et al.
Plos One|July 9, 2011
A PTG variant contributes to a milder phenotype in Lafora diseaseRosa Guerrero, Santiago Vernia, Raúl Sanz, et al.
Diabetes|July 28, 2004
Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutationAntonio L Cuesta-Muñoz, Hanna Huopio, Timo Otonkoski, et al.
Epilepsy & Behavior : E&B|August 28, 2025
The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readinessMeredith I Williams, Katherine J Donohue, Pascual Sanz, et al.
Plos One|October 4, 2016
Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to HumansLuis Sendra, Antonio Miguel, Daniel Pérez-Enguix, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Molecular Cell|November 14, 2017
An Attachment-Independent Biochemical Timer of the Spindle Assembly CheckpointJunbin Qian, Maria Adelaida García-Gimeno, Monique Beullens, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 21, 2011
Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolismPhilippe Couarch, Santiago Vernia, Isabelle Gourfinkel-An, et al.
Protein Science : a Publication of the Protein Society|July 1, 2005
Structure-function analysis of the alpha5 and the alpha13 helices of human glucokinase: description of two novel activating mutationsLeda Pedelini, Maria Adelaida Garcia-Gimeno, Alberto Marina, et al.
Human Molecular Genetics|October 9, 2003
Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulationMaria Elena Fernández-Sánchez, Olga Criado-García, Karen E Heath, et al.
International Journal of Molecular Sciences|January 21, 2023
Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative StressCarlos Romá-Mateo, Sheila Lorente-Pozo, Lucía Márquez-Thibaut, et al.
ACS Chemical Neuroscience|December 28, 2021
Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington DiseaseMarta Vela, María Adelaida García-Gimeno, Ana Sanchis, et al.
Plos One|July 9, 2011
A PTG variant contributes to a milder phenotype in Lafora diseaseRosa Guerrero, Santiago Vernia, Raúl Sanz, et al.
Diabetes|July 28, 2004
Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutationAntonio L Cuesta-Muñoz, Hanna Huopio, Timo Otonkoski, et al.
Epilepsy & Behavior : E&B|August 28, 2025
The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readinessMeredith I Williams, Katherine J Donohue, Pascual Sanz, et al.
Plos One|October 4, 2016
Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to HumansLuis Sendra, Antonio Miguel, Daniel Pérez-Enguix, et al.
Pageof 11